IPC The Hospitalist
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict IPC The Hospitalist's revenues will grow 14.2% and EPS will shrink -5.9%.
The average estimate for revenue is $134.6 million. On the bottom line, the average EPS estimate is $0.48.
Last quarter, IPC The Hospitalist reported revenue of $127.7 million. GAAP reported sales were 12% higher than the prior-year quarter's $114.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.46. GAAP EPS of $0.46 for Q3 were 21% higher than the prior-year quarter's $0.38 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 26.7%, 90 basis points better than the prior-year quarter. Operating margin was 9.7%, 40 basis points better than the prior-year quarter. Net margin was 6.1%, 50 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $520.5 million. The average EPS estimate is $1.91.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 71 members out of 75 rating the stock outperform, and four members rating it underperform. Among 16 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 16 give IPC The Hospitalist a green thumbs-up, and give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on IPC The Hospitalist is outperform, with an average price target of $43.80.
Is IPC The Hospitalist the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add IPC The Hospitalist to My Watchlist.